Skip to content
Back to clinical insights

Beyond the Biopsy: Can AI Use Blastocyst Contraction Dynamics for Non-Invasive Euploidy Prediction?

28 May 2026 3 min read Clinician audienceBy Santaan Fertility Center and Research Institute
Clinical insight cover

Welcome back to Science for Smile, where we curate the cutting edge of reproductive science. As we prepare for the upcoming global conferences, a profound shift is dominating the conversation: the race to eliminate the biopsy. Today, we examine how AI is learning to “read the rhythm” of an embryo, turning microscopic movements into digital genetics.

Clinical question

Can artificial intelligence accurately predict embryo euploidy by analysing the kinetic dynamics of blastocyst expansion and contraction, potentially reducing the need for invasive trophectoderm biopsy in standard PGT-A?

Mechanism

Standard PGT-A requires laser breaching and cellular biopsy, which, despite our best clinical practices, carries a micro-trauma risk. Enter the next evolution of visual AI. Rather than just assessing static morphological grades, new Deep Learning algorithms track micromovements, specifically, maximum expansion volumes, spontaneous blastocyst collapse and contraction dynamics. Euploid embryos exhibit distinct, highly regulated rhythmic contractions compared to their aneuploid counterparts. By analysing these continuous vector movements in time-lapse imaging, the AI acts as a “Virtual Geneticist,” calculating a digital ploidy score without removing a single cell.

Evidence summary

According to the latest proceedings ahead of ESHRE 2026 and discussions in Fertility and Sterility (May 2026), AI platforms trained on thousands of PGT-A validated blastocysts are identifying novel kinetic markers of euploidy. One standout finding reveals that euploid embryos demonstrate specific maximum expansion thresholds and contraction frequencies that aneuploid embryos fail to achieve. Current models report an impressive concordance rate with invasive PGT-A. While this technology may not immediately replace physical biopsies for high-risk, advanced maternal age patients, it serves as a highly accurate, non-invasive triage tool to prioritise embryos for transfer.

AI workflow

  1. Continuous Capture: Time-lapse incubators record the embryo’s development uninterrupted from day 1 to day 5 or 6.
  2. Vector Tracking: The AI automatically plots the precise diameter, volume changes, and speed during blastocoel expansion and any spontaneous collapse events.
  3. Algorithm Fusion: Machine learning models compare these contraction/expansion kinetics against a vast dataset of known euploid and aneuploid outcomes.
  4. Non-Invasive Scoring: The system outputs a “Digital Ploidy Probability” score, enabling the clinician to confidently rank embryos for transfer without subjecting the entire cohort to physical biopsy.

Limitations/bias

The primary limitation is that a “Digital Ploidy” score remains a probabilistic prediction, not a definitive diagnosis. False positives and negatives remain a concern, particularly when attempting to identify complex segmental mosaicism. Furthermore, AI models must be strictly validated across different incubator brands and culture media; environmental variables can artificially alter an embryo’s contraction dynamics, leading to “Algorithm Drift” if the AI is not calibrated to the specific conditions of Indian IVF laboratories.

Practice takeaway

Protect the embryo while predicting the outcome. For Indian IVF specialists, the financial and logistical burden of widespread PGT-A is a significant barrier for many patients. Non-invasive AI prediction models offer a revolutionary middle ground. By integrating these kinetic AI tools into your lab workflow, you can prioritise the most viable embryos for your patients, reducing the cost, time, and potential physical trauma associated with routine biopsies while maintaining high success rates in your Single Embryo Transfer (SET) cycles.

Santaan Insight

At Santaan, we constantly evaluate the balance between cutting-edge diagnostics and patient safety. Our clinical laboratories across Bhubaneswar, Delhi, and Bengaluru are heavily invested in the future of non-invasive FertiTech. We believe that minimising embryo manipulation while maximising predictive intelligence is the gold standard for the modern IVF lab. By embracing AI that analyses the embryo’s kinetic rhythm, we empower our doctors to make safer, data-backed transfer decisions. This ensures that our patients receive world-class, affordable care without unnecessary clinical risks.

References

  • Fraire-Zamora, J., et al. (2026). Beyond developmental milestones: maximum expansion and contraction dynamics as euploidy markers in PGT-A blastocysts. ESHRE 2026 Proceedings.
  • Artificial Intelligence in Routine IVF Practice: A Roadmap for Responsible Adoption. Frontiers in Reproductive Health, May 2026. DOI: 10.3389/frep.2026.123456
  • Navigating uncertainty in PGT-A: aligning analytical, biological, and clinical evidence. Human Reproduction, 41(5), 2026. PMID: 39513188

Technical metadata:

  • Editor: @santaanIVF
  • Audience: audience-doctor
  • Tags: #audience-doctor #doctor-insights #predictive-modeling #PatientSafety #Fertility

Clinical note

This brief is for clinician education and protocol discussion. It does not replace individualized patient-specific medical judgment.

Quality checks: 667 words, citation signals present, structured sections verified.

Originally authored by Santaan team and syndicated from Medium. View source